Dong L, Yin Y, Lu H, Sun D, Wang D, Zou D
Front Med (Lausanne). 2025; 11:1432137.
PMID: 39911665
PMC: 11793997.
DOI: 10.3389/fmed.2024.1432137.
Zhang S, Cao G, Shen S, Wu Y, Tan X, Jiang X
PeerJ. 2024; 12:e18428.
PMID: 39544420
PMC: 11562775.
DOI: 10.7717/peerj.18428.
Lai T, Li F, Xiang L, Liu Z, Li Q, Cao M
Transl Cancer Res. 2024; 13(9):4786-4799.
PMID: 39430830
PMC: 11483424.
DOI: 10.21037/tcr-23-2373.
Yin C, Sun Y, Li H, Zheng X
Heliyon. 2024; 10(18):e37769.
PMID: 39309825
PMC: 11416538.
DOI: 10.1016/j.heliyon.2024.e37769.
Pan Y, You B, Zhao X, Zhang S, Li W
BMC Cancer. 2024; 24(1):525.
PMID: 38664644
PMC: 11046807.
DOI: 10.1186/s12885-024-12275-w.
RNA m6A methylation regulators in liver cancer.
Xu Q, Ren N, Ren L, Yang Y, Pan J, Shang H
Cancer Cell Int. 2024; 24(1):1.
PMID: 38166832
PMC: 10763310.
DOI: 10.1186/s12935-023-03197-x.
inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK4.
Si T, Huang L, Liang T, Huang P, Zhang H, Zhang M
Cancer Biol Ther. 2023; 24(1):2246198.
PMID: 37773732
PMC: 10543352.
DOI: 10.1080/15384047.2023.2246198.
Identifying Network Biomarkers in Early Diagnosis of Hepatocellular Carcinoma via miRNA-Gene Interaction Network Analysis.
Yang Z, Qi Y, Wang Y, Chen X, Wang Y, Zhang X
Curr Issues Mol Biol. 2023; 45(9):7374-7387.
PMID: 37754250
PMC: 10529263.
DOI: 10.3390/cimb45090466.
Ephrin-A4 Ligand (EFNA4) Predicts Poor Prognosis of Hepatocellular Carcinoma and Promotes Tumor Proliferation.
Ye P, Chen Z, Lou H, Mai Y, Zhu X, Fu X
J Clin Exp Hepatol. 2023; 13(5):767-773.
PMID: 37693261
PMC: 10482992.
DOI: 10.1016/j.jceh.2023.04.004.
ETV4 facilitates proliferation, migration, and invasion of liver cancer by mediating TGF-β signal transduction through activation of B3GNT3.
Zhou Z, Wu B, Chen J, Shen Y, Wang J, Chen X
Genes Genomics. 2023; 45(11):1433-1443.
PMID: 37523127
DOI: 10.1007/s13258-023-01428-z.
Role of miR-424 in the carcinogenesis.
Ghafouri-Fard S, Askari A, Hussen B, Taheri M, Dilmaghani N
Clin Transl Oncol. 2023; 26(1):16-38.
PMID: 37178445
PMC: 10761534.
DOI: 10.1007/s12094-023-03209-2.
miR-9 and miR-181a Target Gab2 to Inhibit the Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells.
Huang L, Liu R, Zhou P, Tian Y, Lu Z
Genes (Basel). 2022; 13(11).
PMID: 36421826
PMC: 9690539.
DOI: 10.3390/genes13112152.
The pathogenesis of liver cancer and the therapeutic potential of bioactive substances.
Gao S, Jiang X, Wang L, Jiang S, Luo H, Chen Y
Front Pharmacol. 2022; 13:1029601.
PMID: 36278230
PMC: 9581229.
DOI: 10.3389/fphar.2022.1029601.
Post-Transcriptional Effects of miRNAs on PCSK7 Expression and Function: miR-125a-5p, miR-143-3p, and miR-409-3p as Negative Regulators.
Malakootian M, Naeli P, Mowla S, Seidah N
Metabolites. 2022; 12(7).
PMID: 35888711
PMC: 9323720.
DOI: 10.3390/metabo12070588.
Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma.
Yang L, Zou T, Chen Y, Zhao Y, Wu X, Li M
Hepatol Int. 2022; 16(4):741-754.
PMID: 35648301
DOI: 10.1007/s12072-022-10351-6.
BAP31 Promotes Proliferation, Invasion, and Metastasis of Liver Cancer Cells via Activating PI3K/AKT Pathway.
Sun M, Liu X, Wei W, Ge N, Luo S, Shen S
J Healthc Eng. 2022; 2022:7686728.
PMID: 35449837
PMC: 9017443.
DOI: 10.1155/2022/7686728.
Evaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma.
Garajei A, Parvin M, Mohammadi H, Allameh A, Hamidavi A, Sadeghi M
Pathogens. 2022; 11(2).
PMID: 35215154
PMC: 8875679.
DOI: 10.3390/pathogens11020211.
